Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026)
Beam Therapeutics (BEAM) posted Interest & Investment Income of $6.09 million for Q3 2026, down 44.1% from $10.9 million a year earlier and down 18.6% from the prior quarter.
Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Interest & Investment Income at Beam Therapeutics was $34.09 million, down 22.6% year-over-year; for FY2025, it was $43.73 million, down 10.9% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 110.8% (FY2020 to FY2025).
- In prior years, Beam Therapeutics' Interest & Investment Income was $49.09 million in FY2024 (+5.2%), $46.68 million in FY2023 (+205.1%), $15.3 million in FY2022 and -$9,000 in FY2021.
- The Q3 2026 figure stands as the lowest quarterly Interest & Investment Income since Q3 2022.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 480.2%; the weakest was Q3 2026, with a decline of 44.1%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $7.49 million (Q2 2026), $9.87 million (Q1 2026) and $10.64 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Beam Therapeutics | 2.60 Bn | -2.05 Bn | - | 6.09 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.09 Mn |
| Jun 30, 2026 | 7.49 Mn |
| Mar 31, 2026 | 9.87 Mn |
| Dec 31, 2025 | 10.64 Mn |
| Sep 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 12.33 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 10.93 Mn |
| Sep 30, 2024 | 12.13 Mn |
| Jun 30, 2024 | 14.19 Mn |
| Mar 31, 2024 | 11.85 Mn |
| Dec 31, 2023 | 12.06 Mn |
| Sep 30, 2023 | 12.70 Mn |
| Jun 30, 2023 | 11.95 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 7.61 Mn |
| Sep 30, 2022 | 4.98 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 644,000.00 |
| Dec 31, 2021 | 54,000.00 |
Beam Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BEAM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();